logo-loader
viewCanopy Growth Corporation

Canopy Growth Corporation and Acreage Holdings remind shareholders to support $3.4B mega merger

Voting on the massive deal is now open for shareholders and will close at 10 am EST on June 17

pot
The merger is contingent upon the US federal government legalizing cannabis by 2026

Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) and Acreage Holdings Inc (OTCMKTS:ACRGF) (CSE:ACRG.U) reminded shareholders Friday to support the proposed mega merger of the cannabis companies.

Canadian marijuana producer Canopy Growth has agreed to spend US$3.4 billion to acquire Acreage Holdings, a New York-based cannabis operator licensed in 20 states. In addition, Canopy will pay Acreage shareholders US$300 million.

Voting on the massive deal is now open for shareholders and will close at 10 a.m. EST on June 17. Approval is expected.

However, the merger is contingent upon the US federal government legalizing cannabis within the next seven and a half years.

READ: Canopy Growth acquires London skincare company This Works for $54 million

The global legal marijuana market size is expected to be over $65 billion by 2025, and the Smith Falls, Ontario-based Canopy Growth seems poised to be a dominate player. 

Acreage shareholders “are expected to benefit from accelerated expansion, improved scale, and a stronger market position in the US, powered by the IP and brand rights of the world's leading cannabis company,” according to a statement.

“For Canopy Growth shareholders, the transaction represents a clear path for Canopy Growth to enter the US cannabis market, when federally permissible, and will introduce its brands and consumer products in the US.”

As shareholder voting commences, Canopy’s stock recently traded down 2.7% to US$40.76 a share, while Acreage’s stock fell 1.7% to US$18.16 on the OTC Markets and was done 1.6% to US$18.19 on the CSE.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: Canopy Growth Corporation

Price: 26.6 CAD

TSX:WEED
Market: TSX
Market Cap: $9.27 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Medicenna Therapeutics completes Phase 2B study on cancer drug mdna55

Medicenna Therapeutics (TSE: MDNA) CFO Elizabeth Williams joined Steve Darling from Proactive Vancouver at LD MIcrocap Conference in Vancouver with news about their lead drug mdma55. Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and commercialization...

9 hours, 36 minutes ago

2 min read